Found 394 matching trials
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy PHASE1 The study is an open label, non-randomized study designed to evaluate the d...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET PHASE2 This is a phase 2, open-label, randomized study of adjuvant treatment in su...
Show More Location
Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino
Learn More & Join Trial
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer NA This study aims to evaluate the imaging characteristics of \[⁶⁸Ga\]Ga-GS24-...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma NA In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Show More Location
China, Hubei Province
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan PHASE2 The purpose of this study is to assess the efficacy, tolerability, safety, ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
PSMA in Gastroenterologic Tumors (GIPSMA) NA The theranostic principle is based on the use of radiolabeled compounds whi...
Show More Location
University Hospital Wuerzburg
Learn More & Join Trial
Mechanisms of Resistance to PSMA Radioligand Therapy N/A This is a multicenter, correlative study to existing Lutetium based prostat...
Show More Location
University of California, Los Angeles
Learn More & Join Trial